Marsit C - Search Results

1

Penalized item response theory models: application to epigenetic alterations in bladder cancer.

Houseman EA, Marsit C, Karagas M, Ryan LM. Houseman EA, et al. Among authors: marsit c. Biometrics. 2007 Dec;63(4):1269-77. doi: 10.1111/j.1541-0420.2007.00806.x. Epub 2007 May 2. Biometrics. 2007. PMID: 17484774

2

Carcinogen exposure and gene promoter hypermethylation in bladder cancer.

Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A, Nelson HH, Kelsey KT. Marsit CJ, et al. Carcinogenesis. 2006 Jan;27(1):112-6. doi: 10.1093/carcin/bgi172. Epub 2005 Jun 29. Carcinogenesis. 2006. PMID: 15987713

3

Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer.

Marsit CJ, Karagas MR, Andrew A, Liu M, Danaee H, Schned AR, Nelson HH, Kelsey KT. Marsit CJ, et al. Cancer Res. 2005 Aug 15;65(16):7081-5. doi: 10.1158/0008-5472.CAN-05-0267. Cancer Res. 2005. PMID: 16103055

4

Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer.

Hirao S, Hirao T, Marsit CJ, Hirao Y, Schned A, Devi-Ashok T, Nelson HH, Andrew A, Karagas MR, Kelsey KT. Hirao S, et al. Cancer. 2005 Nov 1;104(9):1918-23. doi: 10.1002/cncr.21423. Cancer. 2005. PMID: 16149093 Free article.

5

Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors.

Marsit CJ, Houseman EA, Christensen BC, Eddy K, Bueno R, Sugarbaker DJ, Nelson HH, Karagas MR, Kelsey KT. Marsit CJ, et al. Cancer Res. 2006 Nov 1;66(21):10621-9. doi: 10.1158/0008-5472.CAN-06-1687. Cancer Res. 2006. PMID: 17079487

6

Carcinogen exposure and epigenetic silencing in bladder cancer.

Marsit CJ, Karagas MR, Schned A, Kelsey KT. Marsit CJ, et al. Ann N Y Acad Sci. 2006 Sep;1076:810-21. doi: 10.1196/annals.1371.031. Ann N Y Acad Sci. 2006. PMID: 17119258

7

Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma.

Hsiung DT, Marsit CJ, Houseman EA, Eddy K, Furniss CS, McClean MD, Kelsey KT. Hsiung DT, et al. Among authors: marsit cj. Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):108-14. doi: 10.1158/1055-9965.EPI-06-0636. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17220338

8

Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer.

Marsit CJ, Houseman EA, Schned AR, Karagas MR, Kelsey KT. Marsit CJ, et al. Carcinogenesis. 2007 Aug;28(8):1745-51. doi: 10.1093/carcin/bgm116. Epub 2007 May 23. Carcinogenesis. 2007. PMID: 17522068

9

Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems.

Schned AR, Andrew AS, Marsit CJ, Zens MS, Kelsey KT, Karagas MR. Schned AR, et al. J Urol. 2007 Oct;178(4 Pt 1):1196-200; discussion 1200. doi: 10.1016/j.juro.2007.05.126. Epub 2007 Aug 14. J Urol. 2007. PMID: 17698105

10

Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma.

Christensen BC, Godleski JJ, Marsit CJ, Houseman EA, Lopez-Fagundo CY, Longacker JL, Bueno R, Sugarbaker DJ, Nelson HH, Kelsey KT. Christensen BC, et al. Among authors: marsit cj. Carcinogenesis. 2008 Aug;29(8):1555-9. doi: 10.1093/carcin/bgn059. Epub 2008 Feb 28. Carcinogenesis. 2008. PMID: 18310086 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters